Evidence map›Paper›PMID 36067147›Full record

ArticlePloS one2022

Cancer symptom clusters in adult patients undergoing chemotherapy: A systematic review and meta-analysis protocol.

Luís Carlos Lopes-Júnior, Taiani Ferrarini, Luciana Bicalho Cevolani Pires, Jonathan Grassi Rodrigues, Luciane Bresciani Salaroli, Karolini Zuqui Nunes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Review
  8. Health Policies for Rare Disease Patients: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Luís Carlos Lopes-JúniorHealth Sciences Center at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.ORCID 0000-0002-2424-6510
Taiani FerrariniHealth Sciences Center at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.
Luciana Bicalho Cevolani PiresGraduate Program in Nutrition and Health at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.ORCID 0000-0002-2760-9663
Jonathan Grassi RodriguesGraduate Program in Public Health at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.ORCID 0000-0001-5477-5109
Luciane Bresciani SalaroliGraduate Program in Nutrition and Health at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.ORCID 0000-0002-1881-0306
Karolini Zuqui NunesHealth Sciences Center at the Federal University of Espírito Santo (UFES), Vitoria, Espírito Santo, Brazil.
Universidade Federal do Espírito Santo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn oncology, the prevalence of symptoms is preferentially analyzed in isolation instead of being considered in clusters. However, clinical practice shows that symptoms rarely occur separately but rather form clusters that share common underlying mechanisms in terms of intensity and severity, creating a synergistic effect among them, which can even help predict the development of future symptoms.

objectiveTo identify and gather evidence on the prevalence, composition, severity, and predictors of cancer symptom clusters in adult cancer patients undergoing chemotherapy.

methodsThis systematic review and meta-analysis protocol was developed in compliance with PRISMA-P. Observational and experimental study designs will be included. MEDLINE/PubMed, Cochrane Library, Embase, CINAHL, PsycINFO, Web of Science, Scopus, LILACS, clinical trials.gov-NIH, the British Library, Google Scholar, and preprints [medRXiv] will be searched with no restrictions on idioms, dates, or settings. Two investigators will independently select the studies, perform data extraction, and critically appraise the risk of bias of the included studies. Heterogeneity among the studies will be assessed using the I2 statistic. If meta-analysis was feasible, a random-effect model analysis will be carried out. For data analysis, the pooled effect will be estimated considering 95% confidence interval and α = 5%. In addition, the certainty of evidence will be rated based on Cochrane methods in accordance with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). DISCUSSION: To the best of our knowledge, this systematic review and meta-analysis will be the first to identify and critically assess evidence regarding the prevalence, composition, severity, and predictors of cancer symptom clusters in adult cancer patients undergoing chemotherapy. We intend to provide health professionals with subsidies to reflect on a better understanding of symptom clusters in adult cancer patients, with the aim of contributing to the development of evidence-based therapeutic interventions and success in clinical practice. PROSPERO REGISTRATION NUMBER: CRD42021248406.

Indexed as

NeoplasmsAdultHealth PersonnelHumansMeta-Analysis as TopicSyndromeSystematic Reviews as Topic

Identifiers

PMID36067147
PMCPMC9447873
OpenAlexW4294795704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.